NITROFINN® – Important additional strenght to Innventa portfolio

NITROFINN® - Important additional strenght to Innventa portfolio After launching of Serapinn forte®, Forticolinn®, Miocytinn®, Laringinn® and Rhinosinn®, Innventa is continuing with fulfillment of ambitious 2018 new products launch plan. On 20th of July 2018 in Serbian pharmacies  is available new product in Innventa urology portfolio - Nitrofinn®. Nitrofinn® is currently the only registered Nitrofurantoin [...]

By |2018-08-01T18:56:40+01:00August 1st, 2018|News|

Innventa Pharm on FASUS

At the Hyat Regency Hotel, on March 9, 2018, in the organization of BB Soft, XXIX Pharmaceutical Meeting FASUS was held. A large number of pharmacists, health technicians, wholesalers and pharmaceutical companies are gathered. More than 500 exhibitors, participants and visitors had the opportunity to exchange knowledge and experiences in the field of pharmacy. At [...]

By |2018-04-09T06:28:11+01:00March 16th, 2018|News|

Exponential growth-Innventa in HealthCare&Lifescience Review Serbia

In interview for the prestigious international publication, general director of INNventa-pharm, Goran Orlic, discusses the rationale behind establishing his own company that continues to double revenues year on year. He highlighted the company’s fundamental role in providing innovative solutions to Serbian patients, pharmacists and doctors. Pharmaboardroom is the official Internet platform of HealthCare & Lifescience [...]

By |2018-03-11T19:08:42+01:00March 2nd, 2018|News|

Expanding of Innventa otorhinolaryngology portfolio-Laringinn and Rhinosinn

In addition to Serapinn product that has been successfully prescribed and used for a year and a half in the treatment of inflammation processes, and Serapinn forte launched in December 2017, Innventa has expanded its Otorhinolaryngology portfolio with two new products Laringinn and Rhinosinn. These two products are sprays for nose and throat used in [...]

By |2018-03-16T12:15:21+01:00March 2nd, 2018|News|

New products from Innventa

Following ambitious new product introduction plan in H1 2018, Innventa have launched on Serbian, Bosnian an Montenegro market: Serapinn® Forte 120.000 SPU Serapinn® Forte 120.000 SPU is the extension of already very well established brand Serapinn, this time in form that due to double concentration of active ingredient (proteolitic enzyme Serrapeptase) presents the product of [...]

By |2018-03-01T13:05:52+01:00February 9th, 2018|News|

INNventa 2018 FIT TO WIN kick off meeting

Fit to win 2018 Innventa kick-off meeting was held from January 27th to February 3rd in unique atmosphere of Costa Diadema cruiser on Western Mediterranean. The analyse of 2017  great achievements was done and ambitious goals for 2018strengthening are presented. In 2017 sales was 98,5% versus budget and 186,5% versus previous year, while budgeted sales growth [...]

By |2018-03-01T12:04:30+01:00February 9th, 2018|News|

The first joint meeting

Innventa team held the first joint meeting in Vršac in June where H1 2016 results were analyzed and strategy of appearing with new products by the end of the year, was agreed. The meeting was attended by the whole sales force together with the newly hired members from Novi Sad and Niš that will cover [...]

By |2018-03-01T12:04:31+01:00July 6th, 2016|News|